Li Y - Search Results

1

The design of antagonist peptide of hIL-6 based on the binding epitope of hIL-6 by computer-aided molecular modeling.

Feng J, Li Y, Shen B. Feng J, et al. Among authors: li y. Peptides. 2004 Jul;25(7):1123-31. doi: 10.1016/j.peptides.2004.04.009. Peptides. 2004. PMID: 15245871

2

A novel TNFalpha antagonizing peptide-Fc fusion protein designed based on CDRs of TNFalpha neutralizing monoclonal antibody.

Qin W, Feng J, Zhang W, Li Y, Shen B. Qin W, et al. Among authors: li y. Biochem Biophys Res Commun. 2004 Sep 24;322(3):1024-8. doi: 10.1016/j.bbrc.2004.07.208. Biochem Biophys Res Commun. 2004. PMID: 15336567

3

A novel hIL-6 antagonist peptide from computer-aided design contributes to suppression of apoptosis in M1 cells.

Yang Z, Feng J, Hu M, Li Y, Yu M, Qin W, Shen B. Yang Z, et al. Among authors: li y. Biochem Biophys Res Commun. 2004 Dec 10;325(2):518-24. doi: 10.1016/j.bbrc.2004.10.065. Biochem Biophys Res Commun. 2004. PMID: 15530423

4

Structure-based design and characterization of a Novel IL-6 antagonist peptide.

Yang Z, Feng J, Li Y, Hu M, Song L, Yu M, Qin W, Shen B. Yang Z, et al. Among authors: li y. Mol Immunol. 2005 May;42(9):1015-21. doi: 10.1016/j.molimm.2004.09.033. Epub 2004 Nov 23. Mol Immunol. 2005. PMID: 15829291

5

Rational design of potent mimic peptide derived from monoclonal antibody: antibody mimic design.

Feng J, Li Y, Zhang W, Shen B. Feng J, et al. Among authors: li y. Immunol Lett. 2005 May 15;98(2):311-6. doi: 10.1016/j.imlet.2004.12.006. Epub 2005 Jan 5. Immunol Lett. 2005. PMID: 15860233

6

De novo design TNF-alpha antagonistic peptide based on the complex structure of TNF-alpha with its neutralizing monoclonal antibody Z12.

Qin W, Feng J, Li Y, Lin Z, Shen B. Qin W, et al. Among authors: li y. J Biotechnol. 2006 Aug 20;125(1):57-63. doi: 10.1016/j.jbiotec.2006.01.036. Epub 2006 Mar 7. J Biotechnol. 2006. PMID: 16522339

7

The rational designed antagonist derived from the complex structure of interleukin-6 and its receptor affectively blocking interleukin-6 might be a promising treatment in multiple myeloma.

Feng J, Yang Z, Li Y, Hu M, Yu M, Qin W, Sun J, Shen B. Feng J, et al. Among authors: li y. Biochimie. 2006 Sep;88(9):1265-73. doi: 10.1016/j.biochi.2006.03.003. Epub 2006 Mar 31. Biochimie. 2006. PMID: 16626851

8

Structured to reduce the mitogenicity of anti-CD3 antibody based on computer-guided molecular design.

Lv M, Li Y, Yu M, Sun Y, Lin Z, Qiao C, Luo Q, Gu X, Huang Y, Feng J, Shen B. Lv M, et al. Among authors: li y. Int J Biochem Cell Biol. 2007;39(6):1142-55. doi: 10.1016/j.biocel.2007.02.015. Epub 2007 Feb 28. Int J Biochem Cell Biol. 2007. PMID: 17446118

9

A novel human scFv fragment against TNF-alpha from de novo design method.

Chang H, Qin W, Li Y, Zhang J, Lin Z, Lv M, Sun Y, Feng J, Shen B. Chang H, et al. Among authors: li y. Mol Immunol. 2007 Jul;44(15):3789-96. doi: 10.1016/j.molimm.2007.03.020. Epub 2007 May 7. Mol Immunol. 2007. PMID: 17485112

10

Protein kinase ERK contributes to differential responsiveness of human myeloma cell lines to IFNalpha.

Song L, Li Y, Shen B. Song L, et al. Among authors: li y. Cancer Cell Int. 2002 Jul 8;2(1):9. doi: 10.1186/1475-2867-2-9. Cancer Cell Int. 2002. PMID: 12234375 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239,632 results

Search Page

Filters